Can Biomedical Innovation Better Reflect What Patients Value? – ASCO
American Society of Clinical Oncology (ASCO)/LinkedIn

Can Biomedical Innovation Better Reflect What Patients Value? – ASCO

American Society of Clinical Oncology (ASCO) shared on LinkedIn:

“In the race for biomedical innovation, have the metrics we use to evaluate progress in cancer care drifted from what patients value most?

In this episode of the ASCO Education:

By the Book Podcast, Dr. Gerald Hsu and Dr. Christopher Booth discuss re-centering oncology care on shared decision-making, patient priorities, and global access.

Can Biomedical Innovation Better Reflect What Patients Value? - ASCO

Highlights include:

  • Moving beyond surrogate endpoints like PFS to prioritize overall survival and quality of life.
  • Addressing total treatment burden, including time toxicity and financial strain.
  • Balancing the ‘Cancer Moonshot’ with an ‘Oncology Groundshot’ for current patients.

Listen here.”

You can also read: Global Research, Local Solutions, Better Cancer Care – Conquer Cancer, the ASCO Foundation

Can Biomedical Innovation Better Reflect What Patients Value? - ASCO